Diabetes, Vol 46, Issue 10 1643-1647, Copyright © 1997 by American Diabetes Association

ARTICLES

Identification of mutations in the hepatocyte nuclear factor (HNF)-1 alpha gene in Japanese subjects with IDDM

S Yamada, H Nishigori, H Onda, T Utsugi, T Yanagawa, T Maruyama, K Onigata, K Nagashima, R Nagai, A Morikawa, T Takeuchi and J Takeda
Department of Molecular Genetics, School of Medicine, Gunma University, Maebashi, Japan.

One form of maturity-onset diabetes of the young, MODY3, is characterized by a severe insulin secretory defect, compared with MODY2, a glucokinase-deficient diabetes. It has recently been shown that mutations of the gene encoding the transcription factor hepatocyte nuclear factor (HNF)-1 alpha cause MODY3. Because of the rapid progress to overt diabetes and the high prevalence of required insulin treatment in patients with MODY3, we screened the HNF-1 alpha gene for mutations in Japanese subjects with IDDM. Ten exons and flanking introns of the HNF-1 alpha gene in these subjects were amplified by polymerase chain reaction and direct sequencing of the products. Mutations were identified in three (5.5%) of the 55 unrelated subjects with IDDM. A missense mutation of R272H (replacement of Arg by His in codon 272) in the DNA binding domain of HNF-1 alpha was found in a subject who developed IDDM 1 year after diagnosis of NIDDM at 8 years of age. A frameshift mutation of P291 fsinsC (insertion of a C in a polyC tract around codon 291 for Pro), which would generate a mutant truncated protein of 340 amino acids, was found in a subject who started insulin treatment when hyperglycemia and ketonuria were noticed at 13 years of age. A missense mutation of R583G (replacement of Arg by Gly in codon 583) in the transactivation domain of HNF-1 alpha was found in a subject with sudden-onset IDDM at 20 years of age. None of these mutations were present in 100 nondiabetic subjects (200 normal chromosomes). These results indicate that the HNF-1 alpha gene defects could lead to the development of not only early-onset NIDDM but also IDDM, implicating the importance of subclassification of HNF-1 alpha-deficient IDDM from a classical type of autoimmune-based IDDM in Japanese.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Bellanne-Chantelot, D. Chauveau, J.-F. Gautier, D. Dubois-Laforgue, S. Clauin, S. Beaufils, J.-M. Wilhelm, C. Boitard, L.-H. Noel, G. Velho, et al. Clinical Spectrum Associated with Hepatocyte Nuclear Factor-1{beta} Mutations Ann Intern Med, April 6, 2004; 140(7): 510 - 517. [Abstract] [Full Text] [PDF]

				K. R. Owen, A. Stride, S. Ellard, and A. T. Hattersley Etiological Investigation of Diabetes in Young Adults Presenting With Apparent Type 2 Diabetes Diabetes Care, July 1, 2003; 26(7): 2088 - 2093. [Abstract] [Full Text] [PDF]

				A. P. Lambert, S. Ellard, L. I.S. Allen, I. W. Gallen, K. M. Gillespie, P. J. Bingley, and A. T. Hattersley Identifying Hepatic Nuclear Factor 1{alpha} Mutations in Children and Young Adults With a Clinical Diagnosis of Type 1 Diabetes Diabetes Care, February 1, 2003; 26(2): 333 - 337. [Abstract] [Full Text] [PDF]

				T. Klupa, J. H. Warram, A. Antonellis, M. Pezzolesi, M. Nam, M. T. Malecki, A. Doria, S. S. Rich, and A. S. Krolewski Determinants of the Development of Diabetes (Maturity-Onset Diabetes of the Young-3) in Carriers of HNF-1{alpha} Mutations: Evidence for parent-of-origin effect Diabetes Care, December 1, 2002; 25(12): 2292 - 2301. [Abstract] [Full Text] [PDF]

				S. S. Fajans, G. I. Bell, and K. S. Polonsky Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the Young N. Engl. J. Med., September 27, 2001; 345(13): 971 - 980. [Full Text] [PDF]

				C. A. Aguilar-Salinas, E. Reyes-RodrÍguez, Ma. L. Ordóñez-Sánchez, M. A. Torres, S. Ramírez-Jiménez, A. Domínguez-López, J. R. MartÍnez-Francois, Ma. L. Velasco-Pérez, M. Alpizar, E. GarcÍa-GarcÍa, et al. Early-Onset Type 2 Diabetes: Metabolic and Genetic Characterization in the Mexican Population J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 220 - 226. [Abstract] [Full Text]

				K. C. Chiu, L.-M. Chuang, J. M. Ryu, G. P. Tsai, and M. F. Saad The I27L Amino Acid Polymorphism of Hepatic Nuclear Factor-1{alpha} Is Associated with Insulin Resistance J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2178 - 2183. [Abstract] [Full Text]

				Q.-X. Hua, M. Zhao, N. Narayana, S. H. Nakagawa, W. Jia, and M. A. Weiss Diabetes-associated mutations in a beta -cell transcription factor destabilize an antiparallel "mini-zipper" in a dimerization interface PNAS, February 29, 2000; 97(5): 1999 - 2004. [Abstract] [Full Text] [PDF]

				E. Kawasaki, Y. Sera, K. Yamakawa, T. Abe, M. Ozaki, S. Uotani, N. Ohtsu, H. Takino, H. Yamasaki, Y. Yamaguchi, et al. Identification and Functional Analysis of Mutations in the Hepatocyte Nuclear Factor-1{alpha} Gene in Anti-Islet Autoantibody-Negative Japanese Patients with Type 1 Diabetes J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 331 - 335. [Abstract] [Full Text]

				R. A. Hegele, H. Cao, S. B. Harris, A. J. G. Hanley, B. Zinman, and P. W. Connelly The Private Hepatocyte Nuclear Factor-1{alpha} G319S Variant Is Associated With Plasma Lipoprotein Variation in Canadian Oji-Cree Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 217 - 222. [Abstract] [Full Text] [PDF]

				R. A. Hegele, H. Cao, S. B. Harris, A. J. G. Hanley, and B. Zinman The Hepatic Nuclear Factor-1{alpha} G319S Variant Is Associated with Early-Onset Type 2 Diabetes in Canadian Oji-Cree J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1077 - 1082. [Abstract] [Full Text]